Rodrigues, D.; Fonseca, A.I.; do Carmo, S.; Sereno, J.; Hrynchak, I.; Moreira, J.N.; Gomes, C.; Abrunhosa, A.
Is Copper-61 the New Gallium-68? Automation and Preclinical Proof-of-Concept of 61Cu-Based Radiopharmaceuticals for Prostate Cancer Imaging. Pharmaceuticals 2025, 18, 469.
https://doi.org/10.3390/ph18040469
AMA Style
Rodrigues D, Fonseca AI, do Carmo S, Sereno J, Hrynchak I, Moreira JN, Gomes C, Abrunhosa A.
Is Copper-61 the New Gallium-68? Automation and Preclinical Proof-of-Concept of 61Cu-Based Radiopharmaceuticals for Prostate Cancer Imaging. Pharmaceuticals. 2025; 18(4):469.
https://doi.org/10.3390/ph18040469
Chicago/Turabian Style
Rodrigues, Diana, Alexandra I. Fonseca, Sérgio do Carmo, José Sereno, Ivanna Hrynchak, João N. Moreira, Célia Gomes, and Antero Abrunhosa.
2025. "Is Copper-61 the New Gallium-68? Automation and Preclinical Proof-of-Concept of 61Cu-Based Radiopharmaceuticals for Prostate Cancer Imaging" Pharmaceuticals 18, no. 4: 469.
https://doi.org/10.3390/ph18040469
APA Style
Rodrigues, D., Fonseca, A. I., do Carmo, S., Sereno, J., Hrynchak, I., Moreira, J. N., Gomes, C., & Abrunhosa, A.
(2025). Is Copper-61 the New Gallium-68? Automation and Preclinical Proof-of-Concept of 61Cu-Based Radiopharmaceuticals for Prostate Cancer Imaging. Pharmaceuticals, 18(4), 469.
https://doi.org/10.3390/ph18040469